Literature DB >> 8239652

Thermal stability and activation of bovine lens multicatalytic proteinase complex (proteasome).

B J Wagner1, J W Margolis.   

Abstract

The multicatalytic proteinase complex (MPC; proteasome) can be isolated in a latent form which then can be activated for protein hydrolysis by physiological and nonphysiological treatments, including high temperature. In this study, the temperature dependency profiles for the hydrolysis of Cbz-Gly-Gly-Leu-pNA and Cbz-Val-Gly-Arg-pNA by bovine lens MPC are found to be those expected for a thermostable enzyme, with single optima above 50 degrees C. In contrast, hydrolyses of Cbz-Leu-Leu-Glu-2NNp and alpha 2-crystallin, a lens structural protein, show two temperature transitions, indicating that hydrolysis of these substrates can be activated by elevated temperature. Temperature dependency profiles of peptidase activity in Tris-HCl compared to Hepes buffer suggest that Tris decreases the thermal stability of MPC. After 10 min preincubation in Tris-HCl at 53 degrees C, lens MPC activities are reduced by 50-60% and loss of the major MPC band can be seen on nondenaturing gels. The presence of alpha 2-crystallin during preincubation partially prevents the loss of activity. Although alpha-crystallin has been reported to function as a molecular chaperone, similar protection by other MPC substrates suggests that alpha 2-crystallin stabilized the MPC as a substrate. Our findings indicate both activation and inactivation of the enzyme at elevated temperatures. It is proposed therefore that high temperature activates the MPC but to a more labile form which can be partially stabilized by protein substrates.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8239652     DOI: 10.1006/abbi.1993.1573

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  7 in total

1.  Subcellular redistribution of components of the ubiquitin-proteasome pathway during lens differentiation and maturation.

Authors:  Henrique Girão; Paulo Pereira; Allen Taylor; Fu Shang
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-04       Impact factor: 4.799

2.  Oligomerization with wt αA- and αB-crystallins reduces proteasome-mediated degradation of C-terminally truncated αA-crystallin.

Authors:  Mingxing Wu; Xinyu Zhang; Qingning Bian; Allen Taylor; Jack J Liang; Linlin Ding; Joseph Horwitz; Fu Shang
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-04       Impact factor: 4.799

3.  Optimization of apolipoprotein B mRNA editing by APOBEC1 apoenzyme and the role of its auxiliary factor, ACF.

Authors:  Ann Chester; Violetta Weinreb; Charles W Carter; Naveenan Navaratnam
Journal:  RNA       Date:  2004-07-23       Impact factor: 4.942

4.  Protection from oxidative inactivation of the 20S proteasome by heat-shock protein 90.

Authors:  M Conconi; I Petropoulos; I Emod; E Turlin; F Biville; B Friguet
Journal:  Biochem J       Date:  1998-07-15       Impact factor: 3.857

5.  Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system.

Authors:  Karthik Selvaraju; Arjan Mofers; Paola Pellegrini; Johannes Salomonsson; Alexandra Ahlner; Vivian Morad; Ellin-Kristina Hillert; Belen Espinosa; Elias S J Arnér; Lasse Jensen; Jonas Malmström; Maria V Turkina; Padraig D'Arcy; Michael A Walters; Maria Sunnerhagen; Stig Linder
Journal:  Sci Rep       Date:  2019-07-08       Impact factor: 4.379

6.  Comprehensive Target Screening and Cellular Profiling of the Cancer-Active Compound b-AP15 Indicate Abrogation of Protein Homeostasis and Organelle Dysfunction as the Primary Mechanism of Action.

Authors:  Johannes Gubat; Karthik Selvaraju; Linda Sjöstrand; Dhananjay Kumar Singh; Maria V Turkina; Bernhard Schmierer; Pierre Sabatier; Roman A Zubarev; Stig Linder; Pádraig D'Arcy
Journal:  Front Oncol       Date:  2022-04-22       Impact factor: 5.738

7.  Dienone Compounds: Targets and Pharmacological Responses.

Authors:  Martina Bazzaro; Stig Linder
Journal:  J Med Chem       Date:  2020-11-04       Impact factor: 7.446

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.